To guarantee the safety and authenticity of medicines to patients, in the first half of 2021, 12 million packages of medicines were verified in the system and reached consumers in Latvia, according to the Latvian Medicines Verification Organization (LZVO) data

Vēl nekad sabiedrība nav tik uzmanīgi sekojusi līdzi zāļu izstrādes informācijai, aprakstiem un lietošanas instrukcijām kā šobrīd, Covid-19 pandēmijas laikā.

The Latvian Medicines Verification System (LZVS) has successfully passed all compatibility tests so that the Latvian national system is prepared for European Medicines Verification System (EU Hub) updates / system release 1.9. LZVS is ready to work without interruption and restriction

EMVO remind that even if a product has a (EU) wide authorisation, i.e. licensed in many markets, data should only be uploaded to the EMVS for markets where the product in question is actively being marketed.

In the first quarter of 2021, in the medicines verification system, which guarantees the safety and authenticity of prescription medicines, 5.8 million packages of medicines were verified and have reached consumers.

Tā kā farmācijas uzņēmums “Pfizer” trešdien ir apstiprinājis, ka Meksikā un Polijā ir konstatētas un konfiscētas viltotas Covid-19 vakcīnas, Latvijas Zāļu verifikācijas organizācija (LZVO) aicina visus vakcīnu piegādes procesā iesaistītos pievērst īpašu uzmanību vakcīnu iepakojumam.

In 2020, the Latvian Medicines Verification Organisation (LZVO) has ensured the stable operation of the medicines verification system.

On March 16, new releases were deployed to the Core system of the Latvian medicines verification system (LZVS) and Reporting system.

Zāļu valsts aģentūra un Veselības inspekciju aicina būt piesardzīgiem un iegādāties zāles tikai licencētās interneta vietnēs.